Foroutan, F., Rayner, D. G., Oss, S., Straccia, M., de Vries, R., Raju, S., Ahmed, F., Kingdon, J., Bhagra, S., Tarani, S., Herrera, S., Bhanji, R., Ross, H., Pruett, T., Feng, S., Pereira, M., Rotstein, C., Guyatt, G., & Aleksova, N. (2025). Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients. Clinical Transplantation, 39(2). Portico. https://doi.org/10.1111/ctr.70100

Rowley, E. A., Mitchell, P. K., Yang, D.-H., Lewis, N., Dixon, B. E., Vazquez-Benitez, G., Fadel, W. F., Essien, I. J., Naleway, A. L., Stenehjem, E., Ong, T. C., Gaglani, M., Natarajan, K., Embi, P., Wiegand, R. E., Link-Gelles, R., Tenforde, M. W., & Fireman, B. (2025). Methods to Adjust for Confounding in Test-Negative Design COVID-19 Effectiveness Studies: Simulation Study. JMIR Formative Research, 9, e58981. https://doi.org/10.2196/58981

Gagneur, A., Gutnick, D., Berthiaume, P., Diana, A., Rollnick, S., & Saha, P. (2024). From vaccine hesitancy to vaccine motivation: A motivational interviewing based approach to vaccine counselling. Human Vaccines & Immunotherapeutics, 20(1). https://doi.org/10.1080/21645515.2024.2391625

Davis-Porada, J., George, A. B., Lam, N., Caron, D. P., Gray, J. I., Huang, J., Hwu, J., Wells, S. B., Matsumoto, R., Kubota, M., Lee, Y., Morrison-Colvin, R., Jensen, I. J., Ural, B. B., Shaabani, N., Weiskopf, D., Grifoni, A., Sette, A., Szabo, P. A., … Farber, D. L. (2024). Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues. Immunity, 57(12), 2895-2913.e8. https://doi.org/10.1016/j.immuni.2024.10.003

Wang, Q., Mellis, I. A., Guo, Y., Gherasim, C., Valdez, R., Gordon, A., Ho, D. D., & Liu, L. (2024). Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster. Cell Reports Medicine, 5(9), 101701. https://doi.org/10.1016/j.xcrm.2024.101701

Nuñez Sahr, J., Parcesepe, A. M., You, W., Nash, D., Penrose, K., Wainberg, M. L., Balasubramanian, S., Chan, B. X. J., & Piltch-Loeb, R. (2024). Exploring COVID-19 Vaccine Decision Making: Insights from ‘One-Shot Wonders’ and ‘Booster Enthusiasts.’ International Journal of Environmental Research and Public Health, 21(8), 1054. https://doi.org/10.3390/ijerph21081054

Saad-Roy, C. M., Morris, S. E., Boots, M., Baker, R. E., Lewis, B. L., Farrar, J., Marathe, M. V., Graham, A. L., Levin, S. A., Wagner, C. E., Metcalf, C. J. E., & Grenfell, B. T. (2024). Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy. PLOS Computational Biology, 20(8), e1012211. https://doi.org/10.1371/journal.pcbi.1012211

Anderson, E., Powell, M., Yang, E., Kar, A., Leung, T. M., Sison, C., Steinberg, R., Mims, R., Choudhury, A., Espinosa, C., Zelmanovich, J., Okoye, N. C., Choi, E. J., Marder, G., Narain, S., Gregersen, P. K., Mackay, M., Diamond, B., Levy, T., … Davidson, A. (2024). Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases. JCI Insight, 9(13). https://doi.org/10.1172/jci.insight.180750

Stanley, A. M., Aksyuk, A. A., Wilkins, D., Green, J. A., Lan, D., Shoemaker, K., Tieu, H.-V., Sobieszczyk, M. E., Falsey, A. R., & Kelly, E. J. (2024). Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1401728

Lazarus, J. V., White, T. M., Wyka, K., Ratzan, S. C., Rabin, K., Larson, H. J., Martinon-Torres, F., Kuchar, E., Abdool Karim, S. S., Giles-Vernick, T., Müller, S., Batista, C., Myburgh, N., Kampmann, B., & El-Mohandes, A. (2024). Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023. Nature Medicine, 30(6), 1559–1563. https://doi.org/10.1038/s41591-024-02939-2

Zambrano, L. D., Newhams, M. M., Simeone, R. M., Payne, A. B., Wu, M., Orzel-Lockwood, A. O., Halasa, N. B., Calixte, J. M., Pannaraj, P. S., Mongkolrattanothai, K., Boom, J. A., Sahni, L. C., Kamidani, S., Chiotos, K., Cameron, M. A., Maddux, A. B., Irby, K., Schuster, J. E., … Mack, E. H. (2024). Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023. MMWR. Morbidity and Mortality Weekly Report, 73(15), 330–338. https://doi.org/10.15585/mmwr.mm7315a2

Moore, M., Zhu, Y., Hirsch, I., White, T., Reiner, R. C., Barber, R. M., Pigott, D., Collins, J. K., Santoni, S., Sobieszczyk, M. E., & Janes, H. (2024). Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data. Epidemics, 47, 100768. https://doi.org/10.1016/j.epidem.2024.100768

Kainth, M. K., Sembajwe, G. N., Ahn, H., Qian, M., Carrington, M., Armellino, D., & Jan, S. (2024). Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children. Vaccine, 42(12), 3122–3133. https://doi.org/10.1016/j.vaccine.2024.04.028

Souza, M. S., Farias, J. P., Andreata‐Santos, R., Silva, M. P., Brito, R. D. da S., Duarte Barbosa da Silva, M., Peter, C. M., Cirilo, M. V. de F., Luiz, W. B., Birbrair, A., Vidal, P. O., de Castro‐Amarante, M. F., Candido, E. D., Munhoz, A. S., de Mello Malta, F., Dorlass, E. G., Machado, R. R. G., Pinho, J. R. R., Oliveira, D. B. L., … Amorim, J. H. (2024). Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future. Journal of Medical Virology, 96(2). Portico. https://doi.org/10.1002/jmv.29416

Pires Farias, J., Andreata-Santos, R., Dalety da Silva Brito, R., Silva Souza, M., Moreira Costa Fogaça, M., Ramos Pinheiro, J., Ferreira da Cruz, E., Liang, W., Simões, R. da C., Barros Luiz, W., Birbrair, A., Oliveira Vidal, P., Terzi Maricato, J., Torres Braconi, C., Ferreira, L. C. de S., Ramos Janini, L. M., & Amorim, J. H. (2023). The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.02857-23

Turley, C. B., Tables, L., Fuller, T., Sanders, L. J., Scott, H., Moodley, A., Woodward Davis, A., Leav, B., Miller, J., Schoemaker, K., Vandebosch, A., Sadoff, J., Woo, W., Cho, I., Dunkle, L. M., Li, S., van der Laan, L., Gilbert, P. B., Follmann, D., … Luedtke, A. (2023). Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials. Vaccine, 41(33), 4899–4906. https://doi.org/10.1016/j.vaccine.2023.06.066

Long, J., Soni, M., Muranski, P., Miller, M. J., Conry-Cantilena, C., & De Giorgi, V. (2023). Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1207638

Harris, J. N., Mauro, C., Andresen, J. A., Zimet, G. D., & Rosenthal, S. L. (2022). COVID-19 vaccine uptake and attitudes towards mandates in a nationally representative U.S. sample. Journal of Behavioral Medicine, 46(1–2), 25–39. https://doi.org/10.1007/s10865-022-00317-2

Link-Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., Hartmann, E., Dickerson, M., Stenehjem, E., Kharbanda, A. B., Han, J., Spark, T. L., Irving, S. A., Dixon, B. E., Zerbo, O., … Tenforde, M. W. (2023). Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods. JAMA Network Open, 6(3), e232598. https://doi.org/10.1001/jamanetworkopen.2023.2598

Farias, J. P., Pinheiro, J. R., Andreata‐Santos, R., Fogaça, M. M. C., da Silva Brito, R. D., da Cruz, E. F., de Castro‐Amarante, M. F., Pereira, S. S., dos Santos Almeida, S., Moreira, L. M., da Conceição Simões, R., Luiz, W. B., Birbrair, A., Belmok, A., Ribeiro, B. M., Maricato, J. T., Braconi, C. T., de Souza Ferreira, L. C., Janini, L. M. R., & Amorim, J. H. (2023). The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS‐CoV‐2 variant. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28481

Hermann, E. A., Lee, B., Balte, P. P., Xanthakis, V., Kirkpatrick, B. D., Cushman, M., & Oelsner, E. (2022). Association of Symptoms After COVID-19 Vaccination With Anti–SARS-CoV-2 Antibody Response in the Framingham Heart Study. JAMA Network Open, 5(10), e2237908. https://doi.org/10.1001/jamanetworkopen.2022.37908

Ning, W., Xu, W., Cong, X., Fan, H., Gilkeson, G., Wu, X., Hughes, H., & Jiang, W. (2022). COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman. Journal of Autoimmunity, 132, 102896. https://doi.org/10.1016/j.jaut.2022.102896

Bloomstone, S., Fleming, M., Arana, M., D’Angelo, E., Ravenhall, S., & Murrman, M. (2022). COVID-19 Vaccine Administration: Phase 2 of an in Progress Review in New York State Local Health Departments. International Journal of Environmental Research and Public Health, 19(20), 13030. https://doi.org/10.3390/ijerph192013030

Sobieszczyk, M. E., Maaske, J., Falsey, A. R., Sproule, S., Robb, M. L., Frenck, R. W., Tieu, H.-V., Mayer, K. H., Corey, L., Neuzil, K. M., Tong, T., Brewinski Isaacs, M., Janes, H., Bansal, H., Edwards, L. M., Green, J. A., Kelly, E. J., Shoemaker, K., Takas, T., … Hirsch, and I. (2022). Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months. Journal of Clinical Investigation, 132(18). https://doi.org/10.1172/jci160565

Sacarny, A., & Daw, J. R. (2021). Inequities in COVID-19 Vaccination Rates in the 9 Largest US Cities. JAMA Health Forum, 2(9), e212415. https://doi.org/10.1001/jamahealthforum.2021.2415

Khan, K., Karim, F., Cele, S., Reedoy, K., San, J. E., Lustig, G., Tegally, H., Rosenberg, Y., Bernstein, M., Jule, Z., Ganga, Y., Ngcobo, N., Mazibuko, M., Mthabela, N., Mhlane, Z., Mbatha, N., Miya, Y., Giandhari, J., Ramphal, Y., … Sigal, A. (2022). Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature, 607(7918), 356–359. https://doi.org/10.1038/s41586-022-04830-x

Diaz, D., Chacko, S., Sperling, A., Fleck, E., Louh, I., Trepp, R., & Ye, S. (2022). Assessment of Digital and Community-Based Outreach Interventions to Encourage COVID-19 Vaccination Uptake in an Underserved Community. JAMA Network Open, 5(6), e2217875. https://doi.org/10.1001/jamanetworkopen.2022.17875

Shoaibi, A., Rao, G. A., Voss, E. A., Ostropolets, A., Mayer, M. A., Ramírez-Anguita, J. M., Maljković, F., Carević, B., Horban, S., Morales, D. R., Duarte-Salles, T., Fraboulet, C., Le Carrour, T., Denaxas, S., Papez, V., John, L. H., Rijneek, P. R., Minty, E., Alshammari, T. M., … Ryan, P. B. (2022). Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study. Drug Safety, 45(6), 685–698. https://doi.org/10.1007/s40264-022-01187-y

McAndrew, T., Cambeiro, J., & Besiroglu, T. (2022). Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine. Vaccine, 40(15), 2331–2341. https://doi.org/10.1016/j.vaccine.2022.02.054

Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., Thacker, D., Elias, M. D., Li, J. S., Toro-Salazar, O. H., Anderson, B. R., Atz, A. M., Bohun, C. M., Campbell, M. J., Chrisant, M., D’Addese, L., Dummer, K. B., Forsha, D., Frank, L. H., … Newburger, J. W. (2022). Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination. Circulation, 145(5), 345–356. https://doi.org/10.1161/circulationaha.121.056583

Wang, J., Guo, C., Cai, L., Liao, C., Yi, H., Li, Q., Hu, H., Deng, Q., Lu, Y., Guo, Z., Chen, Z., & Lu, J. (2021). Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.772511

Karim, S. S. A., & Karim, Q. A. (2021). Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. The Lancet, 398(10317), 2126–2128. https://doi.org/10.1016/s0140-6736(21)02758-6